Fibronostics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 24, 2020
- Vertical
- Diagnostics
- Funding URL
- View Funding Page
- Funding Amount:
- $8,000,000
Company Info
- Founders
- Roni Amiel
- Company Description
- Fibronostics is a global diagnostics company, providing non-invasive, algorithmic diagnostics and insights to detect and manage organ lesions caused by metabolic diseases. The company leverages artificial intelligence to screen and measure the progression and prognosis of liver & kidney disease as well as other chronic conditions.
- Market
- Healthcare
- Location
- Orlando, FL, USA